{
    "clinical_study": {
        "@rank": "68889", 
        "arm_group": [
            {
                "arm_group_label": "Transcutaneous auricular vagal stimulation", 
                "arm_group_type": "Active Comparator", 
                "description": "Transcutaneous stimulation at auricular concha"
            }, 
            {
                "arm_group_label": "Transcutaneous auricular non-vagal stimulation", 
                "arm_group_type": "Sham Comparator", 
                "description": "Transcutaneous stimulation at auricular edge"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether transcutaneous auricular vagus nerve\n      stimulation as a complementary therapy is effective in the treatment of pediatric epilepsy."
        }, 
        "brief_title": "Transcutaneous Auricular Vagus Nerve Stimulation for Pediatric Epilepsy", 
        "condition": "Epilepsy", 
        "condition_browse": {
            "mesh_term": "Epilepsy"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosed as epilepsy;\n\n          -  With age between 2-18 years old;\n\n          -  The number and dose of the medication was kept constant no less than eight weeks\n             before intervention;\n\n          -  The patients or their guardians can count the frequency of the seizures and finish\n             the study.\n\n        Exclusion Criteria:\n\n          -  The patient is receiving the VNS therapy;\n\n          -  Accompanied with progressive central nervous system diseases;\n\n          -  Have severe heart, liver ,kidney or blood diseases;\n\n          -  Be pregnant or having the schedule of pregnancy in the study period."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "18 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02004340", 
            "org_study_id": "NSFC-81273829", 
            "secondary_id": "2011CB505201"
        }, 
        "intervention": {
            "arm_group_label": [
                "Transcutaneous auricular vagal stimulation", 
                "Transcutaneous auricular non-vagal stimulation"
            ], 
            "intervention_name": "ear vagus nerve stimulator", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pediatric epilepsy", 
            "transcutaneous vagus nerve stimulation"
        ], 
        "lastchanged_date": "December 3, 2013", 
        "number_of_arms": "2", 
        "official_title": "Transcutaneous Auricular Vagus Nerve Stimulation as a Complementary Treatment for Pediatric Epilepsy", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: National Natural Science Foundation", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "frequency of epileptic seizures", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline at 8, 16, 24 weeks respectively in frequency of epileptic seizures"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02004340"
        }, 
        "responsible_party": {
            "investigator_affiliation": "China  Academy of Chinese Medical Sciences", 
            "investigator_full_name": "Wei He", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Number of participants with adverse events as a measure of safety and tolerability", 
            "safety_issue": "Yes", 
            "time_frame": "participants will be followed for the duration of TVNS intervention, an expected average of 8 weeks\""
        }, 
        "source": "China  Academy of Chinese Medical Sciences", 
        "sponsors": {
            "collaborator": {
                "agency": "Beijing Children's Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "China  Academy of Chinese Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}